Catalyst Wire Dossier Catalyst Wire Dossier

Bojungikki-tang

Bojungikki-tang
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bojungikki-tang, covering 2024-10-01 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]

See pricing